INSTITUT DE CANCEROLOGIE DE L’OUEST (ICO), SITE P PAPIN

ANGERS 8 trials 7 recruiting

8 Registered trials

7 Currently recruiting

Organisation

INSTITUT DE CANCEROLOGIE DE L’OUEST (ICO), SITE P PAPIN

Location

ANGERS, France

Identifier

ORL-000007008

Address

15 rue André Boquel, 49100, France

Departments

Chirurgie
MEDICAL ONCOLOGY
Oncologie
ONCOLOGIE MEDICALE
Oncology
Service de pneumologie

Clinical trials at this site (8)

Search interface

IFCT-2401 SPORADIC a multicenter randomized open label phase II study evaluating the efficacy and the tolerance of adding cemiplimab to Sequ… Recruiting

2024-517316-29-00 Unresectable stage III Non-Small Cell Lung Cancer 4 2025-11-07
Interest of post-operative chemotherapy in patients with localized uterine leiomyosarcoma suspected to have a high-risk of relapse based on … Recruiting

2023-506350-21-00 Localized, resected, FIGO stage I (2018 classification) 4 2025-01-06
An international multicentric randomized phase II evaluating dostarlimab in combination with niraparib versus niraparib alone compared to ch… Recruiting

2024-516782-36-00 metastatic or recurrent endometrial or ovarian carcinos 4 2024-10-15
PRODIGE 70 - CIRCULATE - CIRCULATING TUMOR DNA BASED DECISION FOR ADJUVANT TREATMENT IN COLON CANCER STAGE II Recruiting

2024-515297-27-00 colon carcinoma 5 2024-08-14
Treatment of microstellite stable metastatic colorectal cancer presenting high immune infiltrate with chemotherapy (XELOX or FOLFOX Bevacizu… Recruiting

2024-515788-73-00 MICROSATELLITE STABLE (MSS) METASTATIC COLORECTAL CANCE 4 2024-07-30
Multicentric non-randomized phase II of pembrolizumab in combination with etoposide-cisplatin-based chemotherapy in first-line small cell ov… Recruiting

2024-515310-40-01 Patients with a confirmed diagnosis of ovarian small ce 4 2021-08-04
Hyperthermic Intraperitoneal Chemotherapy in the treatment of Ovarian Cancer relapse Recruiting

2024-517390-24-00 Ovarian epithelial cancer : intraperitoneal resectable 5 2011-04-26
Study of Tumor Alterations Responsive to Targeting Receptor Kinases-2 Ended

2023-505034-10-00 Locally Advanced or Metastatic Solid Tumors that Harbor 4 2016-08-01